These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18097760)

  • 1. Changes at the focus of experimental ischemic stroke treated with neuroprotective agents.
    Onishchenko LS; Gaikova ON; Yanishevskii SN
    Neurosci Behav Physiol; 2008 Jan; 38(1):49-54. PubMed ID: 18097760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the focus of experimental ischemic stroke under the influence of neuroprotective drugs].
    Onishchenko LS; Gaĭkova ON; Ianishevskiĭ SN
    Morfologiia; 2006; 130(6):40-6. PubMed ID: 17338215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complex application 2-ethyl-6-methyl-3-hydroxypyridine-succinate and vinpocetine in cerebrovascular disorder.].
    Solovyeva EY; Karneev AN; Chekanov AV; Baranova OA; Choi IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):103-108. PubMed ID: 28638040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinpocetine. Monograph.
    Altern Med Rev; 2002 Jun; 7(3):240-3. PubMed ID: 12126465
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group.
    De Deyn PP; Reuck JD; Deberdt W; Vlietinck R; Orgogozo JM
    Stroke; 1997 Dec; 28(12):2347-52. PubMed ID: 9412612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].
    Bagoly E; Fehér G; Szapáry L
    Orv Hetil; 2007 Jul; 148(29):1353-8. PubMed ID: 17631470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke].
    Dézsi L; Kis-Varga I; Nagy J; Komlódi Z; Kárpáti E
    Acta Pharm Hung; 2002; 72(2):84-91. PubMed ID: 12498034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial.
    Gharagozli K; Harandi AA; Houshmand S; Akbari N; Muresanu DF; Vester J; Winter S; Moessler H
    J Med Life; 2017; 10(3):153-160. PubMed ID: 29075343
    [No Abstract]   [Full Text] [Related]  

  • 9. Citicoline preclinical and clinical update 2009-2010.
    Dávalos A; Secades J
    Stroke; 2011 Jan; 42(1 Suppl):S36-9. PubMed ID: 21164116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Efficacy of Cerebrolysin and Cerebrolysin plus Nootropics in the Treatment of Patients with Acute Ischemic Stroke in Vietnam.
    Tran L; Alvarez XA; Le HA; Nguyen DA; Le T; Nguyen N; Nguyen T; Nguyen T; Vo T; Tran T; Duong C; Nguyen H; Nguyen S; Nguyen H; Le T; Nguyen M; Nguyen T
    CNS Neurol Disord Drug Targets; 2022; 21(7):621-630. PubMed ID: 34414874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrolysin and Aquaporin 4 Inhibition Improve Pathological and Motor Recovery after Ischemic Stroke.
    Catalin B; Rogoveanu OC; Pirici I; Balseanu TA; Stan A; Tudorica V; Balea M; Mindrila I; Albu CV; Mohamed G; Pirici D; Muresanu DF
    CNS Neurol Disord Drug Targets; 2018; 17(4):299-308. PubMed ID: 29692268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of neuroprotectors with choline-positive action on the level of brain-injury markers during acute ischemic stroke].
    Vaizova OE; Zautner NA; Alifirova VM; Vengerovskiĭ AI
    Eksp Klin Farmakol; 2012; 75(3):7-9. PubMed ID: 22679745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does treatment with piracetam in stroke patients with aphasia make sense?].
    Schmidtke K
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2636. PubMed ID: 12469280
    [No Abstract]   [Full Text] [Related]  

  • 14. Hope Dies Last-Evidence Again Fails to Support a Neuroprotectant: Cerebrolysin for Acute Ischemic Stroke.
    Bereczki D
    Stroke; 2017 Sep; 48(9):2343-2344. PubMed ID: 28747461
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebrolysin: a multi-target drug for recovery after stroke.
    Brainin M
    Expert Rev Neurother; 2018 Aug; 18(8):681-687. PubMed ID: 30004268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative analysis of efficacy of certain neuroprotectors in ischemic stroke].
    Skorokhodov AP; Dudina AA; Kolesnikova EA; Koron AE; Kobantsev IuA; Sedova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 17():52-6. PubMed ID: 18193579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatio-temporal assessment of the neuroprotective effects of neuregulin-1 on ischemic stroke lesions using MRI.
    Wang S; Li Y; Paudyal R; Ford BD; Zhang X
    J Neurol Sci; 2015 Oct; 357(1-2):28-34. PubMed ID: 26183085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients.
    Zhang F; Yan C; Wei C; Yao Y; Ma X; Gong Z; Liu S; Zang D; Chen J; Shi FD; Hao J
    Transl Stroke Res; 2018 Apr; 9(2):174-184. PubMed ID: 28691141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to improve post-stroke behavioral recovery in aged subjects.
    Buga AM; Bălşeanu A; Popa-Wagner A; Mogoantă L
    Rom J Morphol Embryol; 2009; 50(4):559-82. PubMed ID: 19942950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrolysin dose-dependently improves neurological outcome in rats after acute stroke: A prospective, randomized, blinded, and placebo-controlled study.
    Zhang L; Chopp M; Lu M; Zhang T; Winter S; Doppler E; Meier D; Chao L; Eapen A; Pabla P; Gang Zhang Z
    Int J Stroke; 2016 Apr; 11(3):347-55. PubMed ID: 26763925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.